Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness von Chan, Arlene

Volltext

Breast cancer bone metastases: pathogenesis and therapeutic targets von Brook, Naomi, Brook, Emily, Dharmarajan, Arun, Dass, Crispin R., Chan, Arlene

Volltext

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breas... von GIANNI, Luca, ROMIEU, Gilles H, CHAN, Stephen, WARDLEY, Andrew, GREIL, Richard, MOORE, Nicola, PROT, Sylvie, PALLAUD, Celine, SEMIGLAZOV, Vladimir, LICHINITSER, Michail, SERRANO, Sergio V, MANSUTTI, Mauro, PIVOT, Xavier, MARIANI, Paola, ANDRE, Fabrice, CHAN, Arlene, LIPATOV, Oleg

Volltext

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 tria... von Chan, Arlene, Prof, Delaloge, Suzette, MD, Holmes, Frankie A, MD, Moy, Beverly, MD, Iwata, Hiroji, MD, Harvey, Vernon J, MD, Robert, Nicholas J, MD, Silovski, Tajana, MD, Gokmen, Erhan, MD, von Minckwitz, Gunter, Prof, Ejlertsen, Bent, MD, Chia, Stephen K L, MD, Mansi, Janine, MD, Barrios, Carlos H, Prof, Gnant, Michael, Prof, Buyse, Marc, ScD, Gore, Ira, MD, Smith, John, MD, Harker, Graydon, MD, Masuda, Norikazu, MD, Petrakova, Katarina, MD, Zotano, Angel Guerrero, MD, Iannotti, Nicholas, MD, Rodriguez, Gladys, MD, Tassone, Pierfrancesco, Prof, Wong, Alvin, PharmD, Bryce, Richard, MBChB, Ye, Yining, PhD, Yao, Bin, MS, Martin, Miguel, Prof

Volltext

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Brea... von MILES, David W, CHAN, Arlene, HARBECK, Nadia, STEGER, Guenther G, SCHNEEWEISS, Andreas, WARDLEY, Andrew M, CHLISTALLA, Andreas, ROMIEU, Gilles, DIRIX, Luc Y, CORTES, Javier, PIVOT, Xavier, TOMCZAK, Piotr, DELOZIER, Thierry, JOO HYUK SOHN, PROVENCHER, Louise, PUGLISI, Fabio

Volltext

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer von Geyer, Charles E, Forster, John, Lindquist, Deborah, Chan, Stephen, Chan, Arlene, Romieu, C. Gilles, Pienkowski, Tadeusz, Jagiello-Gruszfeld, Agnieszka, Crown, John, Kaufman, Bella, Skarlos, Dimosthenis, Campone, Mario, Davidson, Neville, Berger, Mark, Oliva, Cristina, Rubin, Stephen D, Stein, Steven, Cameron, David

Volltext

HER2 positive metastatic breast cancer: What happens after first line failure? von Arlene Chan

Volltext

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negati... von BASELGA, José, GOMEZ, Patricia, GOEMINNE, Jean-Charles, GRAAS, Marie-Pascale, KENNEDY, M. John, CIRUELOS GIL, Eva Maria, SCHNEEWEISS, Andreas, ZUBEL, Angela, GROOS, Jutta, MELEZINKOVA, Helena, AWADA, Ahmad, GREIL, Richard, BRAGA, Sofia, CLIMENT, Miguel A, WARDLEY, Andrew M, KAUFMAN, Bella, STEMMER, Salomon M, PEGO, António, CHAN, Arlene

Volltext

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast... von WOLFF, Antonio C, LAZAR, Ann A, CHAN, Arlene, HACHEMI, Soulef, STRAHS, Andrew, CINCOTTA, Maria, BERKENBLIT, Anna, KRYGOWSKI, Mizue, KANG, Lih Lisa, MOORE, Laurence, HAYES, Daniel F, BONDARENKO, Igor, GARIN, August M, BRINCAT, Stephen, CHOW, Louis, YAN SUN, NESKOVIC-KONSTANTINOVIC, Zora, GUIMARAES, Rodrigo C, FUMOLEAU, Pierre

Volltext

NFκB-Mediated Mechanisms Drive PEDF Expression and Function in Pre- and Post-Menopausal Oestrogen Levels in Breast Cancer von Brook, Naomi, Gill, Jespal, Dharmarajan, Arun, Chan, Arlene, Dass, Crispin R

Volltext

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial von Cameron, David, Prof, Brown, Julia, Prof, Dent, Rebecca, MD, Jackisch, Christian, MD, Mackey, John, Prof, Pivot, Xavier, MD, Steger, Guenther G, Prof, Suter, Thomas M, Prof, Toi, Masakazu, Prof, Parmar, Mahesh, DPhil, Laeufle, Rita, MD, Im, Young-Hyuck, MD, Romieu, Gilles, MD, Harvey, Vernon, MD, Lipatov, Oleg, MD, Pienkowski, Tadeusz, MD, Cottu, Paul, MD, Chan, Arlene, Prof, Im, Seock-Ah, Prof, Hall, Peter S, PhD, Bubuteishvili-Pacaud, Lida, MD, Henschel, Volkmar, PhD, Deurloo, Regula J, PhD, Pallaud, Celine, PhD, Bell, Richard, Prof

Volltext

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study von BERGH, Jonas, BONDARENKO, Igor M, CHAN, Arlene, DELALOGE, Suzette, XIN HUANG, KERN, Kenneth A, GIORGETTI, Carla, LICHINITSER, Mikhail R, LILJEGREN, Annelie, GREIL, Richard, VOYTKO, Nataliya L, MAKHSON, Anatoly N, CORTES, Javier, LORTHOLARY, Alain, BISCHOFF, Joachim

Volltext

Contralateral Breast Cancer: Influence Of Molecular Subtype, Clinical Features And Treatment Given In A Single Institution Study von Amira, Mohammad, Bhatt, Nikita, Basford, Emily, Chih, HuiJun, Willsher, Peter, Chan, Arlene

Volltext

Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal,... von EIERMANN, Wolfgang, PIENKOWSKI, Tadeusz, PRESS, Michael, SAUTER, Guido, LINDSAY, Mary-Ann, RIVA, Alessandro, BUYSE, Marc, DREVOT, Philippe, TAUPIN, Henry, MACKEY, John R, CROWN, John, SADEGHI, Saeed, MARTIN, Miguel, CHAN, Arlene, SALEH, Mansoor, SEHDEV, Sandeep, PROVENCHER, Louise, SEMIGLAZOV, Vladimir

Volltext

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109) von Nader-Marta, Guilherme, Singer, Christian, Hlauschek, Dominik, DeMichele, Angela, Tarantino, Paolo, de Azambuja, Evandro, Pfeiler, Georg, Martin, Miguel, Balko, Justin M, Nowecki, Zbigniew, Balic, Marija, Brufsky, Adam M, Chan, Arlene, Morris, Patrick G, Haddad, Tufia, Loibl, Sibylle, Liu, Yuan, Soelkner, Lidija, Fesl, Christian, Mayer, Erica L, Gnant, Michael

Volltext

Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada von Charest, Maxime, Sharma, Malika, Chris, Allison, Schnubb, Alexandre, Knox, David C., Wilton, James, Shahin, Rita, Chan, Arlene, Mishra, Sharmistha, Grace, Daniel, Bayoumi, Ahmed M., Maxwell, John, Bogoch, Isaac I., Tan, Darrell H. S.

Volltext

Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study von Fasching, Peter A., Beck, J. Thaddeus, Chan, Arlene, De Laurentiis, Michele, Esteva, Francisco J., Jerusalem, Guy, Neven, Patrick, Pivot, Xavier, Bianchi, Giulia V., Martin, Miguel, Chandiwana, David, Lanoue, Brad, Ridolfi, Antonia, Wang, Yingbo, Rodriguez Lorenc, Karen, Nusch, Arnd

Volltext

Prognostic role of immune environment in luminal B early breast cancer von Chan, Arlene, Gill, Jespal, Chih, HuiJun, Nelson, Delia J.

Volltext

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens von Chan, Arlene, Bauwens, Astrid, Pontre, Sally, Jackson, Sally, McGlone, Frances, Ernenwein, Tracie, Chih, Jun, Reid, Christopher

Volltext

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer von Chan, Arlene, Ruiz-Borrego, Manuel, Marx, Gavin, Chien, A. Jo, Rugo, Hope S., Brufsky, Adam, Thirlwell, Michael, Trudeau, Maureen, Bose, Ron, García-Sáenz, José A., Egle, Daniel, Pistilli, Barbara, Wassermann, Johanna, Cheong, Kerry A., Schnappauf, Benjamin, Semsek, Dieter, Singer, Christian F., Foruzan, Navid, DiPrimeo, Daniel, McCulloch, Leanne, Hurvitz, Sara A., Barcenas, Carlos H.

Volltext